Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
Public ClinicalTrials.gov record NCT01915940. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Subject- and Examiner-masked, Controlled Clinical Trial Designed to Evaluate the Safety and Effectiveness of the Bimatoprost Ocular Insert as Compared to Topical Timolol Solution (0.5%) in Patients With Glaucoma or Ocular Hypertension.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this Phase 2 study is to evaluate whether the Bimatoprost Ocular Insert is non-inferior to that of timolol ophthalmic solution (0.5%) at 12 weeks.
Study identification
- NCT ID
- NCT01915940
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 169 participants
Conditions and interventions
Conditions
Interventions
- Bimatoprost Drug
- Timolol 0.5% Drug
- Placebo Eye Drops Drug
- Placebo Ocular Insert Device
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2013 (Actual)
- Primary completion
- Sep 30, 2014 (Actual)
- Completion
- Nov 14, 2014 (Actual)
- Last update posted
- Apr 20, 2018
2013 – 2014
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sall Medical Research Center | Artesia | California | 90701 | — |
| Scripps Clinic Torrey Pines | La Jolla | California | 92037 | — |
| Eye Research Foundation | Newport Beach | California | 92663 | — |
| UC Davis Dept of Ophthalmology & Vision Science | Sacramento | California | 95817 | — |
| Coastal Research Associates | Atlanta | Georgia | 30076 | — |
| Clayton Eye Center | Morrow | Georgia | 30260 | — |
| Ophthalmology Consultants | St Louis | Missouri | 63131 | — |
| UNC Kittner Eye Center | Chapel Hill | North Carolina | 27517 | — |
| Apex Eye | Madeira | Ohio | 45243 | — |
| Ophthalmology Associates PC | Fort Worth | Texas | 76102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01915940, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01915940 live on ClinicalTrials.gov.